Perfuse Therapeutics reports positive Phase 1/2a trial results for PER-001 intravitreal implant in glaucoma

Formosa Pharmaceuticals and Apotex sign Mexico licensing agreement for clobetasol propionate ophthalmic suspension

Adcentrx's ADRX-0706 granted US FDA Fast Track designation to treat advanced cervical cancer

Ajinomoto and RIBOMIC announce successful extension of nucleic acid aptamer pharmacokinetics

Innovent reports first patient dosed in efdamrofusp alfa (IBI302) Phase 2 study in diabetic macular edema

AstraZeneca secures EU approval for Calquence combo as first-line treatment in mantle cell lymphoma

Bavarian Nordic secures USD143.6m US government contract for freeze-dried smallpox/mpox vaccine supply

Odylia Therapeutics undertakes gene replacement therapy project for NPHP1 retinal dystrophy

Phanes Therapeutics doses first patient in peluntamig-atezolizumab combination clinical study

Beijing Tide's AT2R antagonist TRD205 advances to Phase II trial in chronic post-surgical neuropathic pain

FDA accepts Novo Nordisk's filing application for oral semaglutide 25 mg

Nutshell Therapeutics' NTS071 p53 allosteric reactivator cleared for US clinical trial

Genmab to submit US sBLA for epcoritamab combination therapy in relapsed/refractory follicular lymphoma

Blue Earth Therapeutics initiates Phase 2 trial in metastatic castrate resistant prostate cancer

Armata Pharmaceuticals' AP-SA02 clinical trial receives additional US DoD funding